Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Induction of systemic HIV-1-specific cellular immune responses by oral exposure in the uninfected partner of discordant couples.

Pérez CL, Hasselrot K, Bratt G, Broliden K, Karlsson AC.

AIDS. 2010 Apr 24;24(7):969-74.

PMID:
20397304
2.

Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load.

Hasselrot K, Bratt G, Hirbod T, Säberg P, Ehnlund M, Lopalco L, Sandström E, Broliden K.

AIDS. 2010 Jan 2;24(1):35-43. doi: 10.1097/QAD.0b013e3283329853.

PMID:
19779318
3.

Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals.

Furci L, Lopalco L, Loverro P, Sinnone M, Tambussi G, Lazzarin A, Lusso P.

AIDS. 2002 May 3;16(7):1003-8.

PMID:
11953466
4.

Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.

Suy A, Castro P, Nomdedeu M, García F, López A, Fumero E, Gallart T, Lopalco L, Coll O, Gatell JM, Plana M.

J Infect Dis. 2007 Oct 15;196(8):1191-201. Epub 2007 Sep 17.

PMID:
17955438
5.

Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.

Restrepo C, Rallón NI, del Romero J, Rodríguez C, Hernando V, López M, Peris A, Lozano S, Sempere-Ortells JM, Soriano V, Benito JM.

J Immunol. 2010 Jul 15;185(2):982-9. doi: 10.4049/jimmunol.1000221. Epub 2010 Jun 11.

6.

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.

Oxenius A, Price DA, Dawson SJ, Günthard HF, Fischer M, Perrin L, Ramirez E, Fagard C, Hirschel B, Scullard G, Weber JN, McLean AR, Phillips RE; Swiss HIV cohort study.

AIDS. 2002 Nov 22;16(17):2317-22.

PMID:
12441804
7.

Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use.

Camara M, Dieye TN, Seydi M, Diallo AA, Fall M, Diaw PA, Sow PS, Mboup S, Kestens L, Jennes W.

J Infect Dis. 2010 Mar 15;201(6):835-42. doi: 10.1086/651000.

PMID:
20136413
8.

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA.

Nat Med. 1996 Apr;2(4):412-7.

PMID:
8597950
9.

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21.

10.

HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.

Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, Fennelly G, Dobroszycki J, Spiegel HM, Wiznia A, Rosenberg MG, Nixon DF.

J Immunol. 2003 Apr 15;170(8):4403-10.

11.

Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus.

Nicastri E, Ercoli L, Sarmati L, d'Ettorre G, Iudicone P, Massetti P, Vullo V, Andreoni M.

J Med Virol. 2001 Jul;64(3):232-7.

PMID:
11424109
12.

HIV-specific cytotoxic T lymphocytes in persons exposed through sexual contact with HIV-infected patients.

Zerhouni B.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):172-3. No abstract available.

PMID:
9241118
13.

Detection of HIV-1-specific T-cell immune responses in highly HIV-exposed uninfected individuals by in-vitro dendritic cell co-culture.

Guardo AC, Ruiz-Riol M, Fernández E, Maleno MJ, Bargalló ME, León A, Climent N, García F, Gatell JM, Brander C, Plana M.

AIDS. 2015 Jul 17;29(11):1309-18. doi: 10.1097/QAD.0000000000000728.

PMID:
26091301
14.

Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men.

Hasselrot K, Säberg P, Hirbod T, Söderlund J, Ehnlund M, Bratt G, Sandström E, Broliden K.

AIDS. 2009 Jan 28;23(3):329-33. doi: 10.1097/QAD.0b013e32831f924c.

PMID:
19114861
15.

HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.

Beretta A, Furci L, Burastero S, Cosma A, Dinelli ME, Lopalco L, DeSantis C, Tambussi G, Carrow E, Sabbatani S, Clerici M, Lazzarin A, Siccardi AG.

Immunol Lett. 1996 Jun;51(1-2):39-43.

PMID:
8811343
17.

In untreated HIV-1-infected children, PBMC-associated HIV DNA levels and cell-free HIV RNA levels are correlated to distinct T-lymphocyte populations.

Scott-Algara D, Rouzioux C, Blanche S, Burgard M, Didier C, Rivière Y, Buseyne F.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):553-63. doi: 10.1097/QAI.0b013e3181cf060f.

18.

Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men.

Lo Caputo S, Trabattoni D, Vichi F, Piconi S, Lopalco L, Villa ML, Mazzotta F, Clerici M.

AIDS. 2003 Mar 7;17(4):531-9.

PMID:
12598773
19.

The high frequency of HIV type 1-specific cellular immune responses in seronegative individuals with parenteral and/or heterosexual HIV type 1 exposure.

Murashev BV, Nazarenko OV, Akulova EB, Artemyeva AK, Verevochkin SV, Shaboltas AV, Skochilov RV, Toussova OV, Kozlov AP.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1598-605. doi: 10.1089/AID.2011.0335. Epub 2012 Apr 26.

PMID:
22475222
20.

Altered CD4+ T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1.

Lewandowski D, Marquis M, Aumont F, Lussier-Morin AC, Raymond M, Sénéchal S, Hanna Z, Jolicoeur P, de Repentigny L.

J Immunol. 2006 Jul 1;177(1):479-91.

Supplemental Content

Support Center